Literature DB >> 8256894

Respiratory illness in persons with human immunodeficiency virus infection. The Pulmonary Complications of HIV Infection Study Group.

J M Wallace1, A V Rao, J Glassroth, N I Hansen, M J Rosen, C Arakaki, P A Kvale, L B Reichman, P C Hopewell.   

Abstract

Although the pulmonary complications of advanced human immunodeficiency virus (HIV) infection have been well described, there is little information on respiratory manifestations of earlier disease. This report describes the respiratory disorders diagnosed over an 18-month period in a cohort of persons with or at risk for HIV infection with variable immunologic status. Cohort members were followed routinely and evaluated for respiratory disease by standard diagnostic algorithms. The 18-month incidence of each respiratory diagnosis was determined, and for frequent diagnoses, incidence by transmission category, location of residence, smoking status, CD4 count, and performance score at entry were compared. The most frequent respiratory diagnoses in HIV-seropositive cohort members were common to the general population: upper respiratory infection (33.4%), acute bronchitis (16.0%), acute sinusitis (5.3%), and bacterial pneumonia (4.8%). Pneumocystis carinii pneumonia occurred in 3.9%. Ambulatory respiratory illnesses were reported frequently regardless of immunologic status. The rates of P. carinii pneumonia and bacterial pneumonia were significantly greater in cohort members with entry CD4 counts < 250. Bacterial pneumonia occurred more frequently in injecting drug users and in cohort members with entry Karnofsky scores < 90. Disease stage and demographic and exposure factors are important variables affecting the respiratory manifestations of HIV infection.

Entities:  

Mesh:

Year:  1993        PMID: 8256894     DOI: 10.1164/ajrccm/148.6_Pt_1.1523

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  20 in total

Review 1.  Pneumonia and pregnancy.

Authors:  W S Lim; J T Macfarlane; C L Colthorpe
Journal:  Thorax       Date:  2001-05       Impact factor: 9.139

2.  Community-based respiratory viral infections in HIV positive patients with lower respiratory tract disease: a prospective bronchoscopic study.

Authors:  R F Miller; C Loveday; J Holton; Y Sharvell; G Patel; N S Brink
Journal:  Genitourin Med       Date:  1996-02

Review 3.  [Quantitative cultures in diagnosis of pneumonia--a method for routine practice?].

Authors:  S Ewig; G Marklein; K H Nachtsheim; H Schäfer; B Lüderitz
Journal:  Med Klin (Munich)       Date:  1998-03-15

4.  Interactions between opportunistic micro-organisms and HIV in the lung.

Authors:  J R Clarke; D Israel-Biet
Journal:  Thorax       Date:  1996-09       Impact factor: 9.139

5.  Tobacco use among adults initiating treatment for HIV infection in rural Uganda.

Authors:  Gina R Kruse; David R Bangsberg; Judith A Hahn; Jessica E Haberer; Peter W Hunt; Conrad Muzoora; John P Bennett; Jeffrey N Martin; Nancy A Rigotti
Journal:  AIDS Behav       Date:  2014-07

6.  Predictors of bacterial pneumonia in Evaluation of Subcutaneous Interleukin-2 in a Randomized International Trial (ESPRIT).

Authors:  S L Pett; C Carey; E Lin; D Wentworth; J Lazovski; J M Miró; F Gordin; B Angus; M Rodriguez-Barradas; R Rubio; G Tambussi; D A Cooper; S Emery
Journal:  HIV Med       Date:  2010-08-31       Impact factor: 3.180

Review 7.  AIDS and the lung: update 1995. 2. New developments in the pulmonary diseases affecting HIV infected individuals.

Authors:  D M Mitchell; R F Miller
Journal:  Thorax       Date:  1995-03       Impact factor: 9.139

8.  Risk factors for early hospital readmission in patients with AIDS and pneumonia.

Authors:  R W Grant; E D Charlebois; R M Wachter
Journal:  J Gen Intern Med       Date:  1999-09       Impact factor: 5.128

Review 9.  Cigarette smoking in the HIV-infected population.

Authors:  Shiva Rahmanian; Mary Ellen Wewers; Susan Koletar; Nancy Reynolds; Amy Ferketich; Philip Diaz
Journal:  Proc Am Thorac Soc       Date:  2011-06

Review 10.  Cigarette smoking and HIV: more evidence for action.

Authors:  Nancy R Reynolds
Journal:  AIDS Educ Prev       Date:  2009-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.